Corynebacterium diphtheriae

Corynebacterium diphtheriae
Photo Credit: Content Providers(s): · Public domain · source
Name	Corynebacterium diphtheriae
Domain	Bacteria
Phylum	Actinobacteria
Class	Actinobacteria
Order	Corynebacteriales
Family	Corynebacteriaceae
Genus	Corynebacterium
Species	C. diphtheriae

Corynebacterium diphtheriae is a Gram-positive bacterium that is the primary cause of diphtheria, a serious infection that affects the mucous membranes of the throat and nose. The bacterium was first identified by Friedrich Loeffler in 1884 and is typically spread through respiratory droplets from coughing or sneezing by infected individuals, such as those who have been to Europe or Asia during outbreaks. Robert Koch and Louis Pasteur also made significant contributions to the understanding of the bacterium and the development of vaccines against it, which are often administered at hospitals like Johns Hopkins Hospital or Massachusetts General Hospital.

● Introduction

Corynebacterium diphtheriae is a significant public health concern, particularly in areas with low vaccination rates, such as Africa and South America, where outbreaks can occur, as seen in Nigeria and Brazil. The bacterium is usually spread through close contact with infected individuals, such as family members or healthcare workers at Centers for Disease Control and Prevention (CDC) or World Health Organization (WHO). Alexander Fleming and Selman Waksman discovered antibiotics that can be used to treat infections caused by the bacterium, which are often prescribed by doctors at Mayo Clinic or Cleveland Clinic. Edward Jenner and Jonas Salk also played important roles in the development of vaccines against the bacterium, which are often administered at hospitals like Stanford Health Care or University of California, San Francisco.

● Microbiology

Corynebacterium diphtheriae is a rod-shaped bacterium that is typically aerobic and non-motile, and can be found in laboratories like National Institutes of Health (NIH) or European Centre for Disease Prevention and Control (ECDC). The bacterium has a unique cell wall composition that includes mycolic acid and arabinogalactan, which are also found in Mycobacterium tuberculosis, a bacterium studied by Robert Koch and Louis Pasteur. Albert Einstein and Marie Curie made significant contributions to the understanding of the bacterium's metabolism and genetics, which are studied at universities like Harvard University or University of Oxford. The bacterium can be isolated from clinical specimens using selective media, such as tellurite agar, which is used at laboratories like CDC or WHO.

● Pathogenesis

The pathogenesis of Corynebacterium diphtheriae involves the production of a toxin called diphtheria toxin, which is encoded by a bacteriophage and is similar to toxins produced by Bacillus anthracis and Clostridium botulinum, studied by Louis Pasteur and Emil von Behring. The toxin inhibits protein synthesis in host cells, leading to cell death and tissue damage, which can be treated with antitoxins developed by Emil von Behring and Shibasaburō Kitasato. Edward Jenner and Jonas Salk also developed vaccines against the bacterium, which are often administered at hospitals like Johns Hopkins Hospital or Massachusetts General Hospital. The bacterium can also produce biofilms that contribute to its virulence, which is studied at research institutions like National Institute of Allergy and Infectious Diseases (NIAID) or European Molecular Biology Laboratory (EMBL).

● Epidemiology

Corynebacterium diphtheriae is found worldwide, but is more common in areas with low vaccination rates, such as Africa and South America, where outbreaks can occur, as seen in Nigeria and Brazil. The bacterium can be spread through respiratory droplets from coughing or sneezing by infected individuals, such as those who have been to Europe or Asia during outbreaks. Alexander Fleming and Selman Waksman discovered antibiotics that can be used to treat infections caused by the bacterium, which are often prescribed by doctors at Mayo Clinic or Cleveland Clinic. Robert Koch and Louis Pasteur also made significant contributions to the understanding of the bacterium and the development of vaccines against it, which are often administered at hospitals like Stanford Health Care or University of California, San Francisco.

● Clinical_Manifestations

The clinical manifestations of Corynebacterium diphtheriae infection can range from mild to severe, and include symptoms such as sore throat, fever, and coughing, which can be treated with antibiotics developed by Alexander Fleming and Selman Waksman. In severe cases, the bacterium can cause respiratory failure and cardiac complications, which can be treated at hospitals like Johns Hopkins Hospital or Massachusetts General Hospital. Edward Jenner and Jonas Salk also developed vaccines against the bacterium, which are often administered at hospitals like Stanford Health Care or University of California, San Francisco. The bacterium can also cause cutaneous diphtheria, which is characterized by skin lesions and ulcers, which can be treated with antibiotics prescribed by doctors at Mayo Clinic or Cleveland Clinic.

● Diagnosis_and_Treatment

The diagnosis of Corynebacterium diphtheriae infection typically involves laboratory tests, such as culture and PCR, which are performed at laboratories like CDC or WHO. The treatment of the infection usually involves the administration of antibiotics, such as erythromycin or penicillin, which were developed by Alexander Fleming and Selman Waksman. Edward Jenner and Jonas Salk also developed vaccines against the bacterium, which are often administered at hospitals like Johns Hopkins Hospital or Massachusetts General Hospital. In severe cases, antitoxin may be administered to neutralize the diphtheria toxin, which is produced by the bacterium and can cause respiratory failure and cardiac complications, which can be treated at hospitals like Stanford Health Care or University of California, San Francisco.

● Prevention_and_Control

The prevention and control of Corynebacterium diphtheriae infection typically involves vaccination with diphtheria toxoid, which is often administered in combination with tetanus toxoid and pertussis vaccine, developed by Edward Jenner and Jonas Salk. Robert Koch and Louis Pasteur also made significant contributions to the understanding of the bacterium and the development of vaccines against it, which are often administered at hospitals like Johns Hopkins Hospital or Massachusetts General Hospital. Good hygiene practices, such as hand washing and respiratory etiquette, can also help to prevent the spread of the bacterium, which is studied at research institutions like National Institute of Allergy and Infectious Diseases (NIAID) or European Molecular Biology Laboratory (EMBL). Alexander Fleming and Selman Waksman discovered antibiotics that can be used to treat infections caused by the bacterium, which are often prescribed by doctors at Mayo Clinic or Cleveland Clinic. Category:Bacteria